dihexa pnb-0408 c-met hgfr activator Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion MET – an ideal target
MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Nrf2 Independent Anti Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases Dihexa (PNB 0408) C27H44N4O5 CID 125355097 PubChem Activated HGF c Met Axis in Head and Neck Cancer Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




